ArgipressinCardiovascularSafety Rating 8/10
Primary research areaSeptic shock vasopressor
Research-literature reference data, NOT patient instructions. Not for human use. Consult a licensed clinician for any human application.
Research dose range0.01-0.04 units/min IV infusion for septic shock
AdministrationIntravenous
Safety8/10 · FDA-approved (Pitressin)
NCAA D1Not listed
Price Comparison
Compare vendors
No vendor pricing available for this peptide yet.
Overview
About Argipressin
Mechanism of action
Arginine vasopressin V1/V2 receptor agonist causing systemic vasoconstriction and antidiuresis
Safety profile
Cardiac ischemia, hyponatremia, peripheral ischemia, mesenteric ischemia · Long clinical history; vasoconstriction, hyponatremia possible; critical care staple
🔔 Get notified when the price drops anywhere
No account required. We scan 30+ vendors daily — one email the moment any vendor drops Argipressin below your target.
Related pages